Table 2.
Study | Year | Method | Sample size | Mutation prevalence (%) | Most common substitution |
---|---|---|---|---|---|
Iraq2 | 2012 | PCRReverse hybridization to oligospecific probes | 50 | 48 | 12G>T |
Codon 12, 13 | |||||
Saudi Arabia11 | 2011 | PCRsequencing | 46 | 32 | 12G>A |
Codon 12, 13 | |||||
Turkey12 | 2013 | Codon 12, 13 | 145 | 37.9 | - |
Jordan13 | 2012 | RTPCRbased assay Sanger sequencing | 100 | 44 | 12G>A |
Codon 12, 13 | |||||
India14 | 2009 | PCRsequencing | 53 | 22.64 | 12G>A |
Codon 12, 13 | |||||
Japan15 | 2000 | PCRsequencing | 18 | 50 | 12G>T |
Only Codon 12 | |||||
Thailand16 | 2013 | PCRsequencing | 200 | 23 | 12G>A |
codon 12, 13 and 61 | |||||
China17 | 2010 | PCRsequencing | 101 | 32.7 | 12G>A |
codon 12, 13, 61 | |||||
Korea18 | 2010 | PCRsequencing | 92 | 28.3 | 12G>A |
Codon 12, 13 | |||||
Italy19 | 2011 | PCRsequencing (fluorescencebased) | 478 | 30 | 12G>A |
Codon12, 13, 61 | |||||
UK20 | 2013 | PCRsequencing | 69 | 49.3 (46.4) | 12G>A |
Codon12, 13, 61 | |||||
Germany21 | 2009 | PCRsequencing | 1018 | 39.3 | 12G>A |
Codon 12, 13 | |||||
Slovenia22 | 2010 | RTPCR | 302 | 45.5 | 12G>A |
Codon 12, 13 | |||||
USA23 | 2013 | PCRsequencing | 171 | 31.6 | 12G>T |
Codon 12, 13 | |||||
Australia24 | 2013 | PCRsequencing | 776 | 28 | - |
Codon 12, 13 | |||||
Tunisia25 | 2012 | PCR sequencing | 52 | 23.07 | - |
Codon 12, 13 | |||||
Moroco26 | 2010 | PCRmelting and direct sequencing | 62 | 29 | - |
Codon 12, 13 | |||||
Current study | 2013 | PCRsequencing | 100 | 32 | 12G>C |